Author: Matthew Nelson|| Date Published: August 19, 2020
Ology Bioservices has won a one-year, $106.3M reserve production capacity contract for more than 186M doses of COVID-19 vaccines and other treatments to support the Trump administration's Operation Warp Speed.
Army Contracting Command received eight bids for the firm-fixed-price contract that seeks to address an urgent domestic requirement for aseptic fill and finish services amid the coronavirus pandemic, the Department of Defense said Tuesday.
The Alachua, Fla.-based biopharmaceutical company received $53.1M at the time of award and is expected to complete work by Aug. 10, 2021.
War Data Platform enables standardized data for agentic AI applications Advana modernization includes financial management and application migration Explore AI,…
Noblis MSD has won a five-year, single-award IDIQ contract to provide end-to-end engineering services for the Network Integration Engineering Facility…
The acquisition expands Empower AI’s capabilities in AI, cloud, data management and DevSecOps Highlight Technologies adds digital modernization and AI-driven…
